Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
暂无分享,去创建一个
M. Pellegrini | B. Comin-Anduix | A. Ribas | A. Cochran | Helena Escuin-Ordinas | R. Lo | W. McBride | J. Jiao | H. Herschman | T. Segura | Shuoran Li | Willy Hugo | Lu Sun | M. Atefi | R. Modlin | Rong-Rong Huang | Michael W. Xie | Susan Realegeno | Paige Krystofinski | F. de-Faria | Ariel Azhdam | S. M. D. Komenan | Rong‐Rong Huang
[1] Z. Siprashvili,et al. Advances in skin grafting and treatment of cutaneous wounds , 2014, Science.
[2] Matteo Pellegrini,et al. Comparison of Molecular Signatures from Multiple Skin Diseases Identifies Mechanisms of Immunopathogenesis , 2014, The Journal of investigative dermatology.
[3] M. Jacomy,et al. ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software , 2014, PloS one.
[4] T. Graeber,et al. COX‐2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors , 2014, Molecular oncology.
[5] Andrew Johnston,et al. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients , 2013, BMC Genomics.
[6] F. McCormick,et al. RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. , 2013, Cancer cell.
[7] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[8] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[9] H. Sorg,et al. Wound Repair and Regeneration , 2012, European Surgical Research.
[10] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[11] T. Ishikawa,et al. Cox‐2 gene expression in chemically induced skin papillomas cannot predict subsequent tumor fate , 2010, Molecular oncology.
[12] M. Belvin,et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth , 2010, Nature.
[13] Chao Zhang,et al. RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF , 2010, Nature.
[14] J. Reis-Filho,et al. Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF , 2010, Cell.
[15] K. Kiguchi,et al. Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications , 2009, Nature Protocols.
[16] Pornpimol Charoentong,et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..
[17] Paul G Scott,et al. Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.
[18] R. Buscà,et al. Transcriptional Signature of Epidermal Keratinocytes Subjected to in Vitro Scratch Wounding Reveals Selective Roles for ERK1/2, p38, and Phosphatidylinositol 3-Kinase Signaling Pathways* , 2007, Journal of Biological Chemistry.
[19] F. Marincola,et al. Gene expression profiling of cutaneous wound healing , 2007, Journal of Translational Medicine.
[20] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[21] Philip R. Cohen,et al. Paradoxical activation of Raf by a novel Raf inhibitor. , 1999, Chemistry & biology.
[22] H. Withers,et al. Assay of radiation effects in mouse skin as expressed in wound healing. , 1988, Radiation research.
[23] Allan Balmain,et al. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas , 1984, Nature.
[24] A. McCullough. RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors , 2013 .
[25] R. Gorodetsky. The use of fibrin based matrices and fibrin microbeads (FMB) for cell based tissue regeneration. , 2008, Expert opinion on biological therapy.